Cargando…
Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
BACKGROUND: Cognitive assessment is essential in tracking disease progression in AD. Presently, cohorts including preclinical at-risk participants are recruited by different means, which may bias cognitive and clinical features. We compared recruitment strategies to levels of cognitive functioning....
Autores principales: | Kirsebom, Bjørn-Eivind, Espenes, Ragna, Waterloo, Knut, Hessen, Erik, Johnsen, Stein Harald, Bråthen, Geir, Aarsland, Dag, Fladby, Tormod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676856/ https://www.ncbi.nlm.nih.gov/pubmed/28984581 http://dx.doi.org/10.3233/JAD-170385 |
Ejemplares similares
-
Amyloid Plaques and Symptoms of Depression Links to Medical Help-Seeking due to Subjective Cognitive Decline
por: Espenes, Ragna, et al.
Publicado: (2020) -
In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
por: Hessen, Erik, et al.
Publicado: (2019) -
Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
por: Kirsebom, Bjørn-Eivind, et al.
Publicado: (2018) -
Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau Burden
por: Grøntvedt, Gøril Rolfseng, et al.
Publicado: (2022) -
Detecting At-Risk Alzheimer’s Disease Cases
por: Fladby, Tormod, et al.
Publicado: (2017)